Keyphrases
Female Rats
100%
Cannabinoids
100%
Male Rats
100%
Pentylenetetrazole
100%
Behavioral Response
100%
Convulsion
100%
Molecular Response
100%
Hippocampus
50%
Cannabinoid Receptor 1 (CB1R)
50%
Arrestin2
50%
Epilepsy
33%
Motivation
16%
Adolescent Males
16%
Neurotoxicity
16%
Excitatory Synapse
16%
Sex Differences
16%
World Population
16%
Multiple Injections
16%
Modulatory
16%
Colocalization
16%
Pathological Changes
16%
Temporal Lobe Epilepsy
16%
Synaptic Proteins
16%
Recurrent Seizures
16%
Motor Symptoms
16%
Marihuana
16%
Brain Activity
16%
Most Common Form
16%
Endocytosis
16%
Anticonvulsant
16%
CaMKII
16%
Treatment Line
16%
Non-motor Symptoms
16%
Protein Markers
16%
Antiepileptic Drugs
16%
Focal Epilepsy
16%
Cannabis Sativa
16%
Granule Cell Layer
16%
Chronic Neurological Diseases
16%
Female Adolescents
16%
Epileptic Patients
16%
WIN55,212-2
16%
Acute Symptomatic Seizures
16%
Epilepsy Syndrome
16%
Adolescent Rats
16%
Neuroscience
Pentylenetetrazol
100%
Female Rats
100%
Cannabinoid
100%
Hippocampus
50%
Synapse
16%
Temporal Lobe Epilepsy
16%
Granule Cell
16%
Cannabis
16%
Endocytosis
16%
WIN 55,212-2
16%
Non-Motor Symptoms
16%
Cannabis Sativa
16%
Focal Epilepsy
16%
Receptor
16%
Brain Disease
16%
Anticonvulsant
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pentetrazole
100%
Cannabinoid
100%
Receptor
16%
Syndrome
16%
Temporal Lobe Epilepsy
16%
Cannabis
16%
Anticonvulsive Agent
16%
Focal Epilepsy
16%
Chronic Brain Disease
16%
Cannabis Sativa
16%
WIN 55,212-2
16%